Derynck Mika K has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 17126 shares of Enliven Therapeutics, Inc. ($ELVN) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Not found | A | Stock Option (right to buy) | 17126 | $0.00 | 17,126.0000 | 62,093,795 | 9999.99% | 0.03% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Not found | A | Stock Option (right to buy) | 20491 | $0.00 | 20,491.0000 | 47,072,532 | 9999.99% | 0.04% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Not found | A | Stock Option (right to buy) | 23364 | $0.00 | 23,364.0000 | 35,546,215 | 9999.99% | 0.07% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Not found | A | Stock Option (right to buy) | 16835 | $0.00 | 16,835.0000 | 35,546,215 | 9999.99% | 0.05% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Director | A | Stock Option (right to buy) | 27567 | $0.00 | 27,567.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Derynck Mika K | Director | A | Employee Stock Option (right to buy) | 87373 | $0.00 | 87,373.0000 | 0 | 9999.99% | 0.00% |